Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nomifensine in parkinsonism.

D M Park, L J Findley, P F Teychenne

    British Journal of Clinical Pharmacology
    |January 1, 1977
    PubMed
    Summary

    Nomifensine showed moderate improvement in parkinsonism symptoms like tremor and facial expression. Replacing nomifensine with placebo significantly worsened patient disability, indicating its therapeutic effect.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Correction to: Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.

    Cell death and differentiation·2018
    Same author

    Modular peptide-functionalized gold nanorods for effective glioblastoma multicellular tumor spheroid targeting.

    Biomaterials science·2018
    Same author

    Multiple receptor tyrosine kinases converge on microRNA-134 to control KRAS, STAT5B, and glioblastoma.

    Cell death and differentiation·2014
    Same author

    The cardiovascular effects of bromocriptine in Parkinsonism.

    British journal of clinical pharmacology·2012
    Same author

    Distribution of CD133 reveals glioma stem cells self-renew through symmetric and asymmetric cell divisions.

    Cell death & disease·2011
    Same author

    Inpatient services in neurological practice.

    Journal of the Royal Society of Medicine·2010

    Area of Science:

    • Neurology
    • Pharmacology

    Background:

    • Parkinsonism is a debilitating neurological disorder.
    • Current treatments for Parkinsonism have limitations.

    Purpose of the Study:

    • To evaluate the efficacy of nomifensine in patients with parkinsonism.
    • To compare nomifensine's effects against a placebo control.

    Main Methods:

    • A double-blind, crossover study design was employed.
    • Twenty-nine patients with parkinsonism participated.
    • Clinical assessments were conducted bi-weekly.

    Main Results:

    • Nomifensine demonstrated moderate improvements in tremor, facial expression, and finger flexion.
    • Substitution of nomifensine with placebo led to significant deterioration in physical signs and functional disability (P < 0.001).
    • Elderly patients showed less favorable responses compared to younger patients.

    Conclusions:

    • Nomifensine exhibits therapeutic benefits in managing parkinsonism symptoms.
    • The drug's efficacy is supported by significant worsening upon placebo substitution.
    • Adverse effects, primarily involuntary movements, were noted.

    Related Experiment Videos